| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Legal Officer | SVP, CLO &Secretary | SVP, General Counsel, Sec. +1 more
1 company
Hadas Nicole R. is a SVP, Chief Legal Officer at AKBA. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $821K at current prices.
Our model assigns Hadas Nicole R. a middling insider score of 60/100, based on 10 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -4.8%.
Hadas Nicole R.'s largest disclosed position is in AKBA as SVP, Chief Legal Officer, worth about $821K. The recent filings there lean toward selling, a net 177,124 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 7,803 | $19.89 | $155,188.42 | -7.1% | |
| Jul 3, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,554 | $14.26 | $22,156.47 | -1.4% | |
| Apr 3, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,556 | $9.18 | $14,280.19 | -1.4% | |
| Jan 1, 2017 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,810 | $10.49 | $18,987.99 | -2.1% | |
| Oct 1, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,556 | $8.95 | $13,933.67 | -1.8% | |
| Jul 5, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,557 | $7.47 | $11,625.34 | -1.8% | |
| Apr 4, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,556 | $9.41 | $14,641.96 | -1.8% | |
| Jan 4, 2016 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,811 | $12.28 | $22,239.08 | -2.7% | |
| Oct 2, 2015 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,484 | $8.67 | $12,859.90 | -2.2% | |
| Jul 2, 2015 | AKBA Akebia Therapeutics, Inc. | SVP, General Counsel, Sec. | Sell | 1,484 | $9.54 | $14,160.48 | -2.2% |